06/02/2026 | Press release | Distributed by Public on 06/02/2026 09:44
Tekedia Capital is excited to announce our investment in Mango Medical, a company building agentic surgical planning AI for orthopedic surgery. The company enables surgeons to receive procedure-ready surgical plans in minutes instead of days, bringing a new layer of intelligence into one of the most demanding areas of healthcare.
Why did we invest? I go back to my days at Johns Hopkins University where I took courses such as Computer Integrated Surgery and Surgery for Engineers, the last offered through Johns Hopkins Medicine, the medical school. During that period, I worked on research involving the mechanics of surgery, including thoracic and abdominal procedures performed in experimental settings. Part of my work focused on robotic systems designed to support minimally invasive surgery. I later invented and patented a dexterous robotic system which found applications beyond medicine to space, after the US Government acquired some rights.
One lesson became immediately clear: human systems are fundamentally different from mechanical systems. A robot that assembles automobiles operates in a highly predictable environment. Every component has known dimensions, known tolerances, and repeatable behaviors. Surgery is different. Human anatomy varies. Pathologies vary. Risk factors vary. Every patient introduces unique variables that make planning, decision-making, and execution extraordinarily complex.
Register for Tekedia Mini-MBA edition 20 (June 8 - Sept 5, 2026).
Register for Tekedia AI in Business Masterclass.
Join Tekedia Capital Syndicate and co-invest in great global startups.
Register for Tekedia AI Lab.
That complexity is precisely why surgical intelligence matters. For decades, the medical profession has relied on the skill, experience, and judgment of surgeons to navigate those complexities. Today, artificial intelligence offers an opportunity to augment that expertise by assisting with planning, simulation, preparation, and decision support. We are beginning to see AI move beyond administrative workflows into the clinical core of medicine itself.
Mango Medical is operating at that frontier. By starting with orthopedic surgery, the company has chosen a domain where planning accuracy, procedural preparation, and execution quality can have significant impact on patient outcomes. More importantly, orthopedic surgery provides a pathway into broader surgical specialties where similar intelligence systems can transform how procedures are prepared and executed.
Simply, as AI becomes more deeply integrated into healthcare, companies that help clinicians make better decisions, prepare more effectively, and deliver improved outcomes will create enormous value for patients, providers, and health systems. That conviction is why Tekedia Capital wrote the cheque!
Connect via my LinkedIn | Facebook | X | YouTube